146 related articles for article (PubMed ID: 26422541)
1. Updates in Tumor Profiling in Gastrointestinal Cancers.
Perez K; Safran HP
R I Med J (2013); 2015 Oct; 98(10):21-4. PubMed ID: 26422541
[TBL] [Abstract][Full Text] [Related]
2. Application of next-generation sequencing in gastrointestinal and liver tumors.
Mikhail S; Faltas B; Salem ME; Bekaii-Saab T
Cancer Lett; 2016 May; 374(2):187-91. PubMed ID: 26916979
[TBL] [Abstract][Full Text] [Related]
3. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
[No Abstract] [Full Text] [Related]
4. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.
Li S; Mao M
Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
[TBL] [Abstract][Full Text] [Related]
6. Mutation Profiling of Clinically Advanced Cancers Using Next-Generation Sequencing for Targeted Therapy: A Lifespan Experience.
Friedman K; Resnick MB; Safran H
R I Med J (2013); 2015 Oct; 98(10):16-20. PubMed ID: 26422540
[TBL] [Abstract][Full Text] [Related]
7. Established and Potential Predictive Biomarkers in Gastrointestinal Cancer--c-Kit, Her2, Ras and Beyond.
Koch C; Trojan J
Digestion; 2015; 91(4):294-302. PubMed ID: 25924988
[TBL] [Abstract][Full Text] [Related]
8. Genomic heterogeneity: next-generation sequencing enables biomarker identification for hepatocellular carcinoma.
Ziogas DE; Lykoudis EG; Roukos DH; Glantzounis GK
Biomark Med; 2017 Jul; 11(7):515-518. PubMed ID: 28699774
[No Abstract] [Full Text] [Related]
9. Performance characteristics of the AmpliSeq Cancer Hotspot panel v2 in combination with the Ion Torrent Next Generation Sequencing Personal Genome Machine.
Butler KS; Young MY; Li Z; Elespuru RK; Wood SC
Regul Toxicol Pharmacol; 2016 Feb; 74():178-86. PubMed ID: 26387931
[TBL] [Abstract][Full Text] [Related]
10. Characterization of novel low passage primary and metastatic colorectal cancer cell lines.
Boot A; van Eendenburg J; Crobach S; Ruano D; Speetjens F; Calame J; Oosting J; Morreau H; van Wezel T
Oncotarget; 2016 Mar; 7(12):14499-509. PubMed ID: 26894854
[TBL] [Abstract][Full Text] [Related]
11. Next generation sequencing technologies in cancer diagnostics and therapeutics: A mini review.
Li W; Zhao K; Kirberger M; Liao W; Yan Y
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):91-102. PubMed ID: 26522064
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm.
Furtado LV; Samowitz WS
Virchows Arch; 2017 Aug; 471(2):235-242. PubMed ID: 28551725
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers for personalized medicine in GI cancers.
Zhang SY; Zhang SQ; Nagaraju GP; El-Rayes BF
Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566
[TBL] [Abstract][Full Text] [Related]
14. "OMICS" technologies and their role in foregut primary malignancies.
Farid SG; Morris-Stiff G
Curr Probl Surg; 2015 Oct; 52(10):409-41. PubMed ID: 26527526
[No Abstract] [Full Text] [Related]
15. Understanding next generation sequencing in oncology: A guide for oncologists.
Moorcraft SY; Gonzalez D; Walker BA
Crit Rev Oncol Hematol; 2015 Dec; 96(3):463-74. PubMed ID: 26160606
[TBL] [Abstract][Full Text] [Related]
16. Clinical application of amplicon-based next-generation sequencing in cancer.
Chang F; Li MM
Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
[TBL] [Abstract][Full Text] [Related]
17. Genetic Profiling of Cancers of the Digestive System: Biological Insights and Clinical Implications.
Stenzinger A; Weichert W
Pathobiology; 2017; 84(6):306-322. PubMed ID: 28178700
[TBL] [Abstract][Full Text] [Related]
18. From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers.
Kyrochristos ID; Glantzounis GK; Ziogas DE; Gizas I; Schizas D; Lykoudis EG; Felekouras E; Machairas A; Katsios C; Liakakos T; Cho WC; Roukos DH
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106782
[TBL] [Abstract][Full Text] [Related]
19. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
Cervera P; Fléjou JF
Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
[TBL] [Abstract][Full Text] [Related]
20. Cell-free DNA for the detection of pancreatic, liver and upper gastrointestinal cancers: has progress been made?
Gall TM; Frampton AE; Krell J; Habib NA; Castellano L; Stebbing J; Jiao LR
Future Oncol; 2013 Dec; 9(12):1861-9. PubMed ID: 24295416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
